@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G7KXQWSR-5 skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-Z9TSGBXH-4 skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-RPWBKLMH-2 skos:prefLabel "Ocytociques"@fr, "Oxytocics"@en ; a mesh:Descriptor, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TRHBQ19B-T skos:altLabel "PGE2"@fr, "PGE2"@en, "Prostaglandine E-2-alpha"@fr, "363-24-6 (Dinoprostone)"@fr, "363-24-6 (Dinoprostone)"@en, "K7Q1JQR04M"@fr, "K7Q1JQR04M"@en, "Prostaglandine E2alpha"@fr, "Prostaglandin E2 alpha"@en, "Prostaglandin E2alpha"@en, "PGE2alpha"@fr, "PGE2alpha"@en, "PGE-2"@fr, "Prostaglandine E2-alpha"@fr, "Prostaglandine E2"@fr, "Prostaglandin E2"@en, "PGE2 alpha"@en, "PGE-2-alpha"@fr, "PG-E2"@fr, "PG-E2-alpha"@fr, "Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-"@en, "Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-"@fr ; mesh:allowableQualifier jvr:-T9HQD7ST-J, jvr:-TJHVZCRZ-0, jvr:-H7K65Q8S-Z, jvr:-WK5F724J-1, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9, jvr:-SBNWSM1T-R, jvr:-R3QWLHRG-V, jvr:-G7KXQWSR-5, jvr:-THHNVC7V-3, jvr:-D0F21513-5, jvr:-S0CS1X5R-5, jvr:-NKM836P1-M, jvr:-NFTHND7Q-8, jvr:-WZF2ZR3L-B, jvr:-G4R176S9-J, jvr:-M63HSDM7-1, jvr:-Z9TSGBXH-4, jvr:-NB0XHT3S-N, jvr:-W6SQV79N-S, jvr:-CB30NGKB-3, jvr:-CJXMKG5Q-F, jvr:-BT300B3G-Q, jvr:-HQRFT0C6-B, jvr:-L6C0XPHT-4, jvr:-R0ZCQ8X6-J, jvr:-G30ZJ446-J, jvr:-XV06LPML-W, jvr:-Q3979798-W ; skos:inScheme jvr: ; mesh:pharmacologicalAction jvr:-RPWBKLMH-2 ; skos:prefLabel "Dinoprostone"@en, "Dinoprostone"@fr ; owl:sameAs ; skos:definition "The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa."@en ; dc:modified "2015-06-08"^^xsd:date ; a mesh:Descriptor, skos:Concept ; skos:hiddenLabel "Prostenon"@en, "Prepidil Gel"@en ; dc:created "1988-05-12"^^xsd:date ; skos:broader jvr:-G2HWSD1Q-6 ; dc:established "1989-01-01"^^xsd:date . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CJXMKG5Q-F skos:prefLabel "deficiency (Qualifier)"@en, "déficit (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G2HWSD1Q-6 skos:prefLabel "Prostaglandins E"@en, "Prostaglandines E"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-TRHBQ19B-T . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WZF2ZR3L-B skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .